What is TSN's intrinsic value?

TickerWorth's valuation lenses put Tyson Foods, Inc. (TSN) between $32.22 and $160.41 per share, versus a market price of $54.90. They disagree too widely for us to state a single fair value, so we publish the range.

Is TSN overvalued or undervalued?

At $54.90 the price sits inside a range too wide to call either way. We don't call TSN overvalued or undervalued from a range this wide. This is an educational estimate, not advice.

What discount rate is used for TSN?

A WACC of 7.7% and a terminal growth rate of 2.5%.

Is Tyson Foods stock undervalued?

TickerWorth's fair-value range for Tyson Foods, Inc. (TSN) is $32.22 – $160.41 against a market price of $54.90. Too wide to call. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.

Tyson Foods (TSN) DCF valuation and fair value

Our fair-value range for Tyson Foods, Inc. (TSN) is $32.22 – $160.41, built on a 7.7% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.

What growth is priced into Tyson Foods stock?

no growth rate up to 300%/yr justifies the price under these economics This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $54.90. A model estimate, not investment advice.

Tyson Foods (TSN) insider trading

The most recent insider filing (SEC Form 4) for Tyson Foods, Inc. (TSN): Schomburger Jeffrey K, Director, President & CEO Elect, open-market buy on 2026-09-04. The latest filings are listed on this page. A disclosure, not a signal to trade.

TSN · Intrinsic value

Is Tyson Foods, Inc. (TSN) overvalued or undervalued?

Name: Tyson Foods, Inc. (TSN) DCF intrinsic value
Creator: TickerWorth

As of Oct 19, 2026, TickerWorth's valuation lenses put Tyson Foods, Inc. (TSN) at $32.22 – $160.41, too broad a range to say where the delayed market price of $54.90 sits in it, so we do not call it over- or undervalued. It is a model estimate, and every input behind it is sourced below.

Model by Miraaj Patel · generated from a hand-researched model · Updated Oct 19, 2026 · How these pages are made

Open full TSN analysis

What is TSN worth?

Fair-value range: $32.22 – $160.41
Market price: $54.90
Gap to fair value: —
Verdict: Too wide to call

Price as of 19 Oct 2026, 13:16 UTC · Prices are delayed.Our valuation lenses disagree too widely on this company for us to publish a single number, so we publish the range instead. We do not call it over- or undervalued from a spread this wide.

Fair-value range against the delayed market price: Too wide to call.

Reverse DCF: no growth rate up to 300%/yr justifies the price under these economics

What is TSN's TickerWorth Score?

C56/100

Middle of the pack — real strengths and real weaknesses

Compared with Consumer Defensive companies in US

Its strongest point: trades below our estimate of what it's worth. Its weakest: profitability is weak.

Value · 72 of 100
Cheaper than 72% of Consumer Defensive companies in US
Price vs worth · 87 of 100
Quality · 6 of 100
More profitable than 6% of Consumer Defensive companies in US
Financial health · 59 of 100
Financially stronger than 59% of Consumer Defensive companies in US
Growth · 70 of 100
Growing faster than 70% of Consumer Defensive companies in US
Momentum · 40 of 100
Outperformed 40% of Consumer Defensive companies in US over the past year

Confidence: Medium confidence · Scored 19 Oct 2026, 13:16 UTC

Get the Undervalued Company of the Week.

Where the numbers come from

Hand-researched model

What the modeller flagged

TERMINAL VALUE IS ~81% OF ENTERPRISE VALUE — above the 75% line. Only ~19% of the answer comes from the five explicit years, so this is mostly a bet on the mid-cycle margin. The honest output is a range: the WACC × terminal-growth grid spans roughly $41 to $153.
YEAR-1 FCF IS ~23% ABOVE THE BASE YEAR'S REPORTED FCF ($1,445M modeled vs $1,177M FY2025), past the 20% line. It is explained by capex: guided FY2026 capex of $0.8B vs $978M in FY2025, and the model's tax and D&A follow guidance. The modeled figure sits inside management's own FY2026 FCF guidance of $1.3-1.7B.
BETA NORMALIZED UP from a published 0.395 to 0.75, and cost of debt uses the ~6.1% marginal rate rather than the ~5.1% average. Both lower the value. At the published beta this same model gives ~$100/share — almost exactly the kind of number a generic model taking the feed's beta at face value would produce.
THE MARGIN PATH IS THE SOFTEST INPUT. It assumes a beef recovery that Tyson itself says is not imminent ('supply constraints are likely to persist'). If margins simply stay at ~2.9% from FY2027 onward the value is ~$46/share, below today's price.
BASE AND FORECAST USE A HOUSE MARGIN DEFINITION (GAAP ex non-cash impairments) that is neither Tyson's GAAP figure (2.0% in FY2025) nor its adjusted figure (4.2%). The derivation is in the base_year.ebit_margin note.
SBC (~$100M a year, ~0.2% of sales) is expensed inside GAAP operating income; dilution is carried by the diluted share count.

Why TSN gets a range, not one number

At a recent price of $54.90, Tyson Foods, Inc. (TSN) sits inside a range too wide to call either way: our valuation lenses put the business somewhere between $32.22 and $160.41 per share. They disagree too widely for us to state a single fair value. We publish the range rather than a midpoint because a number that precise would claim more than the methods can support. This is an educational model, not a price target or a recommendation.

Read the full reasoning

The valuation discounts Tyson Foods, Inc.'s projected free cash flows at a weighted-average cost of capital (WACC) of 7.7%, with a long-run terminal growth rate of 2.5%. About 81% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.

Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, TSN's modeled DCF value ranges from about $41.33 to $152.55 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.

How to read this page: the DCF fair value is what Tyson Foods, Inc. would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of TSN's intrinsic value. Figures update as new filings and prices come in.

Every input behind TSN's DCF

Input	Value	Source
Base-year revenueTyson Q4/FY2025 earnings release, 8-K Ex-99.1 (accession 0000100493-25-000094, filed 2025-11-10); ties to FY2025 10-K (accession 0000100493-25-000095): FY2025 Sales $54,441M, +2.1% on FY2024's $53,309M (+3.3% excluding the $653M year-on-year increase in legal contingency accruals, which Tyson books as a REDUCTION TO SALES, not an expense). Segment gross sales: Beef $21,623M, Chicken $16,837M, Prepared Foods $9,930M, Pork $5,781M, International/Other $2,291M, less $2,021M intersegment. UNCHANGED as the base — FY2026 belongs in the forecast. CROSS-CHECK: nine months of FY2026 (to 2026-06-27) sales were $41,834M, +3.1% YoY, consistent with the guided full year.	$54,441,000,000	Tyson Q4/FY2025 earnings release, 8-K Ex-99.1 (accession 0000100493-25-000094, filed 2025-11-10); ties to FY2025 10-K (accession 0000100493-25-000095): FY2025 Sales $54,441M, +2.1% on FY2024's $53,309M (+3.3% excluding the $653M year-on-year increase in legal contingency accruals, which Tyson books as a REDUCTION TO SALES, not an expense). Segment gross sales: Beef $21,623M, Chicken $16,837M, Prepared Foods $9,930M, Pork $5,781M, International/Other $2,291M, less $2,021M intersegment. UNCHANGED as the base — FY2026 belongs in the forecast. CROSS-CHECK: nine months of FY2026 (to 2026-06-27) sales were $41,834M, +3.1% YoY, consistent with the guided full year.
Base EBIT marginTyson Q4/FY2025 earnings release, 8-K Ex-99.1 (accession 0000100493-25-000094, filed 2025-11-10): HOUSE MEASURE = GAAP operating income EXCLUDING ONLY non-cash goodwill/intangible impairments. FY2025 GAAP operating income $1,098M (2.02%) + the $343M non-cash goodwill impairment = $1,441M / $54,441M = 2.65%. Everything else Tyson strips out of its 'adjusted' figure is LEFT IN: the $698M of antitrust legal-contingency accruals (booked against sales) and restructuring/plant-closure charges are cash costs this company has incurred every year — adjusted-vs-GAAP gap was $411M in FY2024, $846M ex-impairment in FY2025, $517M in 9M FY2026. Tyson's own adjusted margin for FY2025 was 4.2% ($2,287M); this base deliberately sits below it. CROSS-CHECK: 9M FY2026 GAAP operating income $1,099M / $41,834M = 2.63% (no impairments at the operating line), essentially the same as this base. The base margin only feeds the cyclical-fade check; cash flows run off the forecast path.	2.6%	Tyson Q4/FY2025 earnings release, 8-K Ex-99.1 (accession 0000100493-25-000094, filed 2025-11-10): HOUSE MEASURE = GAAP operating income EXCLUDING ONLY non-cash goodwill/intangible impairments. FY2025 GAAP operating income $1,098M (2.02%) + the $343M non-cash goodwill impairment = $1,441M / $54,441M = 2.65%. Everything else Tyson strips out of its 'adjusted' figure is LEFT IN: the $698M of antitrust legal-contingency accruals (booked against sales) and restructuring/plant-closure charges are cash costs this company has incurred every year — adjusted-vs-GAAP gap was $411M in FY2024, $846M ex-impairment in FY2025, $517M in 9M FY2026. Tyson's own adjusted margin for FY2025 was 4.2% ($2,287M); this base deliberately sits below it. CROSS-CHECK: 9M FY2026 GAAP operating income $1,099M / $41,834M = 2.63% (no impairments at the operating line), essentially the same as this base. The base margin only feeds the cyclical-fade check; cash flows run off the forecast path.
Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast	2% → 2% → 3% → 3% → 2%	ESTIMATEAssumption — TickerWorth's 5-year explicit forecast
Risk-free rateUS 10Y Treasury constant maturity (FRED DGS10): 5.24% on 2026-10-01, the latest published observation; program-wide rate shared by every researched model.	5.2%	US 10Y Treasury constant maturity (FRED DGS10): 5.24% on 2026-10-01, the latest published observation; program-wide rate shared by every researched model.
BetaESTIMATEAssumption — normalized estimate (published 5Y-monthly beta via yfinance): Published 5Y-monthly beta is 0.395 (yfinance 2026-10-05). NORMALIZED UP to 0.75 — CONSERVATIVE: it raises WACC and LOWERS the value. Reason: at 0.395 the cost of equity is 7.2%, barely 1pp above the ~6.1% Tyson would pay on new BBB/Baa2 debt — equity junior to the bonds cannot plausibly be that cheap. Cross-check by bond-yield-plus-premium: ~6.1% plus the conventional 3-4pp equity premium gives 9.1-10.1%; beta 0.75 gives 8.99%, just under that range. A low market beta also says little about a company whose GAAP operating margin swung from 9.3% (FY2021) to -0.8% (FY2023) in two years. Sizing: the published 0.395 would give ~$100/share; 0.6 ~$81; 0.9 ~$61.	0.75	ESTIMATEAssumption — normalized estimate (published 5Y-monthly beta via yfinance): Published 5Y-monthly beta is 0.395 (yfinance 2026-10-05). NORMALIZED UP to 0.75 — CONSERVATIVE: it raises WACC and LOWERS the value. Reason: at 0.395 the cost of equity is 7.2%, barely 1pp above the ~6.1% Tyson would pay on new BBB/Baa2 debt — equity junior to the bonds cannot plausibly be that cheap. Cross-check by bond-yield-plus-premium: ~6.1% plus the conventional 3-4pp equity premium gives 9.1-10.1%; beta 0.75 gives 8.99%, just under that range. A low market beta also says little about a company whose GAAP operating margin swung from 9.3% (FY2021) to -0.8% (FY2023) in two years. Sizing: the published 0.395 would give ~$100/share; 0.6 ~$81; 0.9 ~$61.
Terminal growthESTIMATEAssumption — house default: House default 2.5% (roughly long-run nominal GDP). Consistent with Tyson's own history — FY2015-FY2025 sales grew ~2.8% a year (XBRL) — and with protein demand that grows with population plus food inflation. Must remain < WACC of 7.67%. At 2.0% the value falls ~$7/share.	2.5%	ESTIMATEAssumption — house default: House default 2.5% (roughly long-run nominal GDP). Consistent with Tyson's own history — FY2015-FY2025 sales grew ~2.8% a year (XBRL) — and with protein demand that grows with population plus food inflation. Must remain < WACC of 7.67%. At 2.0% the value falls ~$7/share.
Diluted sharesTyson Q3 FY2026 10-Q, Note 9 Earnings Per Share (accession 0000100493-26-000058, filed 2026-08-03): Q3 FY2026 diluted weighted-average shares 355M = Class A 282M + Class B 70M (if-converted) + 3M dilutive awards. Outstanding at 2026-06-27: 281,792,507 Class A + 70,009,005 Class B. INCLUDES CLASS B: the unlisted Class B (held by the Tyson family) converts share-for-share into Class A, so every slice of equity is counted. Finance sites quoting ~282M shares and an $18.3B 'market cap' leave Class B out.	355M	Tyson Q3 FY2026 10-Q, Note 9 Earnings Per Share (accession 0000100493-26-000058, filed 2026-08-03): Q3 FY2026 diluted weighted-average shares 355M = Class A 282M + Class B 70M (if-converted) + 3M dilutive awards. Outstanding at 2026-06-27: 281,792,507 Class A + 70,009,005 Class B. INCLUDES CLASS B: the unlisted Class B (held by the Tyson family) converts share-for-share into Class A, so every slice of equity is counted. Finance sites quoting ~282M shares and an $18.3B 'market cap' leave Class B out.
Market priceDelayed quote · as of 2026-10-19 13:16 UTC	$54.90	Delayed quote · as of 2026-10-19 13:16 UTC

Change TSN's assumptions

The discount-rate dial and the editable model

Pro

Change growth, margin and WACC yourself — Pro (7-day free trial, card required).

Start free trial Try it on Apple

What does Tyson Foods, Inc. do?

What does it do?

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. It operates in the Farm Products industry (Consumer Defensive sector), headquartered in United States. The company employs roughly 133,000 people.

How does it make money?

The business turns $55.7B in annual revenue into profit. Out of every $100 of sales, about $3 is left as operating profit (operating margin of 2.7%), after a 7% gross margin on the products/services it sells. After all costs, taxes and interest, 1.0% of revenue becomes bottom-line net profit.

Is it financially healthy?

Financially it looks mixed: carries modest debt (0.4× equity), can just cover its short-term bills (1.4× current ratio), and is currently profitable.

Who at TSN filed insider trades?

Recent insider filings for Tyson Foods, Inc.
Date	Insider	Relationship	What happened	Value	Filing
4 Sept 2026	Schomburger Jeffrey K	Director, President & CEO Elect	Open-market buy	$1,001,616.65	Form 4 for Schomburger Jeffrey K (opens sec.gov in a new tab)
10 Jul 2026	Schomburger Jeffrey K	Director, President & CEO Elect	Grant / award	—	Form 4 for Schomburger Jeffrey K (opens sec.gov in a new tab)
10 Jul 2026	MORRIS WES	Chief Operating Officer	Grant / award	—	Form 4 for MORRIS WES (opens sec.gov in a new tab)
10 May 2026	COLE DEVIN	Chief Operating Officer	Shares withheld (tax)	$513,533.80	Form 4 for COLE DEVIN (opens sec.gov in a new tab)
10 May 2026	COLE DEVIN	Chief Operating Officer	Shares withheld (tax)	$206,165.70	Form 4 for COLE DEVIN (opens sec.gov in a new tab)
9 May 2026	COLE DEVIN	Chief Operating Officer	Shares withheld (tax)	$52,379.08	Form 4 for COLE DEVIN (opens sec.gov in a new tab)

A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans

Common questions

What is TSN's intrinsic value?
TickerWorth's valuation lenses put Tyson Foods, Inc. (TSN) between $32.22 and $160.41 per share, versus a market price of $54.90. They disagree too widely for us to state a single fair value, so we publish the range.
Is TSN overvalued or undervalued?
At $54.90 the price sits inside a range too wide to call either way. We don't call TSN overvalued or undervalued from a range this wide. This is an educational estimate, not advice.
What discount rate is used for TSN?
A WACC of 7.7% and a terminal growth rate of 2.5%.
Is Tyson Foods stock undervalued?
TickerWorth's fair-value range for Tyson Foods, Inc. (TSN) is $32.22 – $160.41 against a market price of $54.90. Too wide to call. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.
Tyson Foods (TSN) DCF valuation and fair value
Our fair-value range for Tyson Foods, Inc. (TSN) is $32.22 – $160.41, built on a 7.7% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into Tyson Foods stock?
no growth rate up to 300%/yr justifies the price under these economics This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $54.90. A model estimate, not investment advice.
Tyson Foods (TSN) insider trading
The most recent insider filing (SEC Form 4) for Tyson Foods, Inc. (TSN): Schomburger Jeffrey K, Director, President & CEO Elect, open-market buy on 2026-09-04. The latest filings are listed on this page. A disclosure, not a signal to trade.